Stealth BioTherapeutics Corp Interest Expense | MITO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Stealth BioTherapeutics Corp

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.24 M	1.81 M	6.67 M	21.4 M	3.28 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
21.4 M	1.24 M	6.87 M

Quarterly Interest Expense Stealth BioTherapeutics Corp

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	1.24 M	-	-	-	1.81 M	1.42 M	-	-	6.67 M	6.01 M	-	-	21.4 M	-	-	-	3.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.4 M	1.24 M	5.97 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	8.51 M	$ 5.32	0.09 %	$ 652 M	USA
ADC Therapeutics SA ADCT	22.7 M	$ 1.05	0.46 %	$ 133 M	Schweiz
Agenus AGEN	72.4 M	$ 7.21	0.7 %	$ 214 M	USA
Akebia Therapeutics AKBA	58 K	$ 0.92	1.64 %	$ 237 M	USA
Alector ALEC	13.2 M	$ 1.93	0.81 %	$ 199 M	USA
Aligos Therapeutics ALGS	2.2 M	$ 5.05	1.2 %	$ 49.9 M	USA
Alkermes plc ALKS	4.47 M	$ 46.07	0.09 %	$ 7.59 B	Irlanda
Allogene Therapeutics ALLO	215 K	$ 1.69	0.58 %	$ 373 M	USA
Alnylam Pharmaceuticals ALNY	5.2 M	$ 239.36	0.46 %	$ 31.4 B	USA
Altimmune ALT	-190 K	$ 3.24	0.31 %	$ 285 M	USA
ALX Oncology Holdings ALXO	1.6 M	$ 1.76	0.53 %	$ 94.4 M	USA
Evelo Biosciences EVLO	61 K	-	-14.46 %	$ 27.9 M	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 23.95	1.31 %	$ 1.12 B	USA
AnaptysBio ANAB	5.43 M	$ 54.31	0.15 %	$ 1.56 B	USA
ANI Pharmaceuticals ANIP	1.93 M	$ 73.59	2.05 %	$ 1.48 B	USA
Aptevo Therapeutics APVO	345 K	$ 1.72	0.58 %	$ 543 K	USA
Allakos ALLK	-43 K	-	-	$ 28.6 M	USA
Aquestive Therapeutics AQST	6.34 M	$ 4.82	0.21 %	$ 515 M	USA
Arcturus Therapeutics Holdings ARCT	10.1 M	$ 15.6	0.25 %	$ 427 M	Israel
Armata Pharmaceuticals ARMP	-137 M	$ 4.07	2.21 %	$ 147 M	USA
Assembly Biosciences ASMB	117 K	$ 25.48	0.54 %	$ 286 M	USA
Actinium Pharmaceuticals ATNM	3.1 M	$ 1.24	0.79 %	$ 38.7 M	USA
AbbVie ABBV	2.89 B	$ 262.51	0.01 %	$ 464 B	USA
Atara Biotherapeutics ATRA	3.79 M	$ 10.11	7.1 %	$ 127 M	USA
Aurinia Pharmaceuticals AUPH	2.78 M	$ 16.96	5.15 %	$ 2.28 B	Canada
Autolus Therapeutics plc AUTL	36.7 M	$ 1.87	0.53 %	$ 498 M	Britain
Axon Enterprise AXON	99.9 M	$ 468.42	5.96 %	$ 36.6 B	USA
Axsome Therapeutics AXSM	-15.9 M	$ 211.97	3.87 %	$ 10.5 B	USA
Aytu BioScience AYTU	-512 K	$ 1.97	0.5 %	$ 12.4 M	USA
BridgeBio Pharma BBIO	43.1 M	$ 68.3	0.1 %	$ 13.1 B	USA
Bicycle Therapeutics plc BCYC	3.26 M	$ 3.64	0.68 %	$ 252 M	Britain
Black Diamond Therapeutics BDTX	5.78 M	$ 1.94	1.02 %	$ 110 M	USA
Biogen BIIB	268 M	$ 216.01	0.42 %	$ 31.6 B	USA
BioLineRx Ltd. BLRX	1.25 M	$ 2.48	0.79 %	$ 6.11 B	Israel
AbCellera Biologics ABCL	-2.71 M	$ 11.67	2.28 %	$ 3.49 B	Canada
Benitec Biopharma BNTC	-43 K	$ 11.04	0.9 %	$ 514 M	USA
Burford Capital Limited BUR	99.1 M	$ 3.87	0.8 %	$ 848 M	Britain
Clovis Oncology CLVS	53 K	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	8.18 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	-309 K	-	-	$ 401 M	USA
Cabaletta Bio CABA	2 M	$ 2.49	0.39 %	$ 250 M	USA
Can-Fite BioPharma Ltd. CANF	561 K	$ 2.24	0.89 %	$ 3.69 M	Israel
Catalyst Biosciences CBIO	-1.5 M	$ 17.18	1.7 %	$ 1.53 B	USA